Related Experiment Video
Updated: Nov 6, 2025

13:42
Multi-parameter Measurement of the Permeability Transition Pore Opening in Isolated Mouse Heart Mitochondria
Published on: September 7, 2012
21.7K
Quantification of Myocardial Mitochondrial Membrane Potential Using PET
Matthieu Pelletier-Galarneau1, Felicitas J Detmer1, Yoann Petibon1
1Gordon Center for Medical Imaging, Massachusetts General Hospital, Harvard Medical School, 125 Nashua St., Boston, MA, 02114, USA.
Current Cardiology Reports
|May 10, 2021
Summary
This study introduces a new method for in vivo tissue membrane potential (ΔΨT) quantification, a proxy for mitochondrial membrane potential (ΔΨm). This technique offers a novel biomarker for cardiovascular diseases.
Area of Science:
- Biomedical imaging
- Cardiovascular research
- Mitochondrial function
Background:
- Mitochondrial membrane potential (ΔΨm) is crucial for cellular energy production.
- In vitro methods for ΔΨm measurement have limitations.
- Tissue membrane potential (ΔΨT) serves as a valuable in vivo proxy for ΔΨm.
Purpose of the Study:
- To present a novel method for in vivo quantification of tissue membrane potential (ΔΨT).
- To review the origin and role of mitochondrial membrane potential (ΔΨm).
- To highlight potential applications of myocardial ΔΨT imaging in cardiovascular diseases.
Main Methods:
- Utilized radiolabeled lipophilic cations, similar to those used for in vitro ΔΨm measurement.
- Employed positron emission tomography (PET) with appropriate compartment modeling.
- Validated the technique in both animal models and human subjects.
Main Results:
- Demonstrated the feasibility of in vivo myocardial ΔΨT quantification using PET.
- Observed low variability in ΔΨT among healthy individuals, indicating sensitivity to pathological changes.
- Established ΔΨT as a potential new biomarker for cardiovascular disease assessment.
Conclusions:
- In vivo assessment of myocardial ΔΨT using PET is a feasible and promising technique.
- This method provides a new tool for studying cardiovascular disease pathophysiology.
- Myocardial ΔΨT imaging has the potential to serve as a biomarker for disease staging, prognosis, and therapeutic response.

